相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Connecting the dots between tau dysfunction and neurodegeneration
Bess Frost et al.
TRENDS IN CELL BIOLOGY (2015)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Transport and diffusion of Tau protein in neurons
Tim Scholz et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Resistance to first line platinum paclitaxel chemotherapy in serous epithelial ovarian cancer: The prediction value of ERCC1 and Tau expression
Karina Dahl Steffensen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Prion-like Properties of Tau Protein: The Importance of Extracellular Tau as a Therapeutic Target
Brandon B. Holmes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The relationships between the chemosensitivity of human gastric cancer to paclitaxel and the expressions of class III β-tubulin, MAPT, and survivin
Wenting He et al.
MEDICAL ONCOLOGY (2014)
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer's Disease
Tara L. Spires-Jones et al.
NEURON (2014)
Lost after translation: missorting of Tau protein and consequences for Alzheimer disease
Hans Zempell et al.
TRENDS IN NEUROSCIENCES (2014)
The role of extracellular Tau in the spreading of neurofibrillary pathology
Miguel Medina et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Acetylation: a new key to unlock tau's role in neurodegeneration
Casey Cook et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Current standards of care for chemotherapy of optimally cytoreduced advanced epithelial ovarian cancer
Maurie Markman
GYNECOLOGIC ONCOLOGY (2013)
Matrix Rigidity Activates Wnt Signaling through Down-regulation of Dickkopf-1 Protein
Maria V. Barbolina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy
Marta Smoter et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Relationship Between Gastric Cancer Tau Protein Expression and Paclitaxel Sensitivity
Qiong Wang et al.
PATHOLOGY & ONCOLOGY RESEARCH (2013)
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke et al.
NATURE COMMUNICATIONS (2013)
The Changing View of High-Grade Serous Ovarian Cancer
Els M. J. J. Berns et al.
CANCER RESEARCH (2012)
First-line Chemotherapy in Epithelial Ovarian Cancer
Michael A. Bookman
CLINICAL OBSTETRICS AND GYNECOLOGY (2012)
Review of Dose-intense Platinum and/or Paclitaxel Containing Chemotherapy in Advanced and Recurrent Epithelial Ovarian Cancer
Ingrid A. Boere et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Key features of extrauterine pelvic serous tumours (fallopian tube, ovary, and peritoneum)
Deborah DeLair et al.
HISTOPATHOLOGY (2012)
Fractalkine Receptor CX(3)CR1 Is Expressed in Epithelial Ovarian Carcinoma Cells and Required for Motility and Adhesion to Peritoneal Mesothelial Cells
Mijung Kim et al.
MOLECULAR CANCER RESEARCH (2012)
The Lymphotactin Receptor Is Expressed in Epithelial Ovarian Carcinoma and Contributes to Cell Migration and Proliferation
Mijung Kim et al.
MOLECULAR CANCER RESEARCH (2012)
Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
Jaime Prat
VIRCHOWS ARCHIV (2012)
The role of Tau protein in resistance to paclitaxel
Marta Smoter et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Nuclear Tau, a Key Player in Neuronal DNA Protection
Audrey Sultan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Predictive and Prognostic Values of Tau and ERCC1 in Advanced Breast Cancer Patients Treated with Paclitaxel and Cisplatin
Yu-Yun Shao et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Tau Overexpression Inhibits Cell Apoptosis with the Mechanisms Involving Multiple Viability-Related Factors
Hai-Hong Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Microenvironmental Regulation of Chemokine (C-X-C- Motif) Receptor 4 in Ovarian Carcinoma
Maria V. Barbolina et al.
MOLECULAR CANCER RESEARCH (2010)
Weekly paclitaxel in the treatment of recurrent ovarian cancer
Richard D. Baird et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Tau expression and efficacy of paclitaxel treatment in metastatic breast cancer
Satoru Tanaka et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion
Maria V. Barbolina et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion
Maria V. Barbolina et al.
CANCER (2008)
Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma
Maria V. Barbolina et al.
LABORATORY INVESTIGATION (2008)
Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer
Fabrice Andre et al.
CLINICAL CANCER RESEARCH (2007)
Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression
Maria V. Barbolina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Reduced tau expression in gastric cancer can identify candidates for successful paclitaxel treatment
K. Mimori et al.
BRITISH JOURNAL OF CANCER (2006)
Tau protein binds to pericentromeric DNA:: a putative role for nuclear tau in nucleolar organization
Marcela K. Sjoberg et al.
JOURNAL OF CELL SCIENCE (2006)
Microtubule associated protein (MAP)-Tau - A novel mediator of paclitaxel sensitivity in vitro and in vivo
P Wagner et al.
CELL CYCLE (2005)
Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer
R Rouzier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Repeat motifs of tau bind to the insides of microtubules in the absence of taxol
S Kar et al.
EMBO JOURNAL (2003)
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
L Buée et al.
BRAIN RESEARCH REVIEWS (2000)
分享论文
